MAPT and Alzheimer disease: In human CSF obtained from an Alzheimer’s Disease Neuroimaging Initiative sample of healthy older controls, we reported that e2 was associated with increased Aβ levels and reduced p-tau levels when contrasted with e3 homozygotes7.